Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (22,286,500) $ (18,031,888)
Adjustments to reconcile net loss to net cash used in operating activities:    
Acquired in-process research and development 871,877
Depreciation 9,634 9,245
Amortization of operating lease right-of-use asset 65,695 61,132
Share-based compensation 790,858 1,057,766
Non-cash interest 623
Forgiveness of note payable (125,501)
Change in operating assets and liabilities:    
Prepaid expenses and other current assets (754,872) (646,475)
Other assets 82,959
Accounts payable (761,833) 93,232
Accrued expenses 893,728 445,278
Deferred income (287,190) 500,000
Operating lease liability (66,991) (60,489)
Net cash used in operating activities (21,525,594) (16,614,118)
Cash flows from investing activities:    
Purchases of in-process research and development (871,877)
Net cash used in investing activities (871,877)
Cash flows from financing activities:    
Proceeds from the issuance of common stock and warrants, net of issuance costs 15,322,839
Proceeds from the exercise of warrants 2
Repayments of related-party notes (20,436)
Net cash provided by financing activities 15,302,405
Net decrease in cash (22,397,471) (1,311,713)
Cash, beginning of period 27,622,067 7,349,903
Cash, end of period 5,224,596 6,038,190
Supplemental disclosure of non-cash investing and financing activities:    
Net settlement of warrants 243
Issuance of common stock on vesting of restricted stock units 33 13
Change in operating lease right-of-use asset and liability due to amended lease $ 213,793